# SAS Intecmedia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sas-intecmedia

- Industry: Internet
- Headquarters: France
- Website: www.digitecpharma.fr
- Total disclosed funding: $1.3M
- Latest round: Series A (Jan 25, 2024)
- Investors on record: 2

## About

SAS Intecmedia, based in France, operates an innovative e-health platform that enhances pharmacy operations and patient management through digital solutions.Founded in 2007 in France, SAS Intecmedia specializes in digital health services. It has successfully completed five deals and raised EUR 399,999.85 in Series A funding on January 25, 2024, from Extens. The company operates with a valuation of EUR 5.39 mn.DigitecPharma offers an innovative e-health platform designed to enhance the operational efficiency of pharmacies and improve patient management. Their core offerings include a comprehensive suite of digital solutions such as a mobile application, a dedicated website, and a Click & Collect service, all aimed at streamlining pharmacy operations and enhancing patient engagement. The platform enables pharmacists to manage patient interactions at the counter, organize pharmacy services, and execute new missions with their teams effectively. By facilitating access to health advice and product information through various digital channels, DigitecPharma seeks to strengthen the pharmacist-patient relationship and extend service availability beyond physical pharmacy locations. This suite of services primarily targets pharmacies across various geographical markets, enhancing their visibility and operational capabilities in the healthcare sector.In the most recent year, 2021, DigitecPharma reported a revenue of EUR 1,154,938.10. The company's revenue model relies on subscription-based services and partnerships with pharmacies, with additional income generated through their Click & Collect service, which enhances customer engagement and operational efficiency for pharmacies.Following the recent Series A funding, SAS Intecmedia plans to further develop and launch new features for its e-health platform aimed at improving pharmacy management. The company is also targeting expansion into additional European markets by mid-2025. The funds raised will be strategically invested to support these product developments and market expansions.

## Funding rounds

- Series A, Jan 25, 2024, $0.4M — Extens
- Series A, Nov 12, 2021, $0.9M — Extens, Région Sud Investissement

## Investors

- Extens (https://capitalatlas.ai/funds/extens) — Series A
- Région Sud Investissement (https://capitalatlas.ai/funds/region-sud-investissement) — Series A